Figure 5.
Hazard ratios (with 95% confidence intervals) for the progression to AD for the two subgroups and all subjects when comparing the placebo and donepezil arms.
Hazard ratios (with 95% confidence intervals) for the progression to AD for the two subgroups and all subjects when comparing the placebo and donepezil arms.